Carregant...
Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions
Maintenance of genomic stability is a critical determinant of cell survival and is necessary for growth and progression of malignant cells. Interstrand crosslinking (ICL) agents, including platinum-based agents, are first-line chemotherapy treatment for many solid human cancers. In malignant cells,...
Guardat en:
| Publicat a: | Curr Med Chem |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5471128/ https://ncbi.nlm.nih.gov/pubmed/27978798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/0929867323666161214114948 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|